Very Small Embryonic-like Stem Cells for Erectile Dysfunction

Organic Erectile Dysfunction Clinical Trial

Official title: Autologous Very Small Embryonic-like Stem Cells(VSELs) for Organic Erectile Dysfunction

Status Withdrawn

Clinical Trial Summary

The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to organic erectile dysfunction, such as those associated with metabolic syndrome or the treatment of prostate cancer.

Clinical Trial Description

By enrolling patients with organic erectile dysfunction adapted to enrolled criteria, this study will document for the first time the safety and efficacy of underlying penile cellular damage. The safety will be evaluated by tolerance degree. The efficacy will be evaluated validated scores and color duplex Doppler ultrasound. ;

Related Conditions & MeSH terms

• Erectile Dysfunction
• Organic Erectile Dysfunction

• NCT number: NCT03973021
• Study type: Interventional
• Source: Fuda Cancer Hospital, Guangzhou
• Status: Withdrawn
• Phase: Phase 1/Phase 2
• Start date: July 1, 2019
• Completion date: July 1, 2020